Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

  • A
    Transfused cells have a limited life span
  • B
    Introduced gene has been mutated
  • C
    The enzyme required is degraded after $20$ days of transfusion
  • D
    Both $(a)$ and $(c)$

Explore More

Similar Questions

Which one of the following molecular diagnostic techniques is used to detect the presence of a pathogen in its early stage of infection?

Which of the following peptide chain is removed during the maturation of proinsulin into insulin?

Which one of the following techniques does not serve the purpose of early diagnosis of a disease for its early treatment?

In transgenics,the expression of transgene in the target tissue is known by:

Maximum application of animal cell culture technology today is in the production of

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo